IGF1 and Cowden syndrome 1: Because activation of the IGF1-signaling pathway is involved in CS pathogenesis (Al-Rekabi et al., 2016; Gustafson et al., 2019), we cannot rule out a possible role for the GSK and ABCC8 variants in CS occurrence in these patients.